257 related articles for article (PubMed ID: 24630491)
1. Blood substitutes: why haven't we been more successful?
Alayash AI
Trends Biotechnol; 2014 Apr; 32(4):177-85. PubMed ID: 24630491
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of Toxicity and Modulation of Hemoglobin-based Oxygen Carriers.
Alayash AI
Shock; 2019 Oct; 52(1S Suppl 1):41-49. PubMed ID: 29112106
[TBL] [Abstract][Full Text] [Related]
3. HBOC vasoactivity: interplay between nitric oxide scavenging and capacity to generate bioactive nitric oxide species.
Cabrales P; Friedman JM
Antioxid Redox Signal; 2013 Jun; 18(17):2284-97. PubMed ID: 23249305
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the oxidative reactivity of recombinant fetal and adult human hemoglobin: implications for the design of hemoglobin-based oxygen carriers.
Simons M; Gretton S; Silkstone GGA; Rajagopal BS; Allen-Baume V; Syrett N; Shaik T; Leiva-Eriksson N; Ronda L; Mozzarelli A; Strader MB; Alayash AI; Reeder BJ; Cooper CE
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29802155
[TBL] [Abstract][Full Text] [Related]
5. All hemoglobin-based oxygen carriers are not created equally.
Buehler PW; Alayash AI
Biochim Biophys Acta; 2008 Oct; 1784(10):1378-81. PubMed ID: 18206989
[TBL] [Abstract][Full Text] [Related]
6. Engineering tyrosine residues into hemoglobin enhances heme reduction, decreases oxidative stress and increases vascular retention of a hemoglobin based blood substitute.
Cooper CE; Silkstone GGA; Simons M; Rajagopal B; Syrett N; Shaik T; Gretton S; Welbourn E; Bülow L; Eriksson NL; Ronda L; Mozzarelli A; Eke A; Mathe D; Reeder BJ
Free Radic Biol Med; 2019 Apr; 134():106-118. PubMed ID: 30594736
[TBL] [Abstract][Full Text] [Related]
7. How Nitric Oxide Hindered the Search for Hemoglobin-Based Oxygen Carriers as Human Blood Substitutes.
Samaja M; Malavalli A; Vandegriff KD
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834350
[TBL] [Abstract][Full Text] [Related]
8. Interaction of recombinant octameric hemoglobin with endothelial cells.
Gaucher C; Domingues-Hamdi É; Prin-Mathieu C; Menu P; Baudin-Creuza V
C R Biol; 2015 Feb; 338(2):95-102. PubMed ID: 25543885
[TBL] [Abstract][Full Text] [Related]
9. Site-specific cross-linking of human and bovine hemoglobins differentially alters oxygen binding and redox side reactions producing rhombic heme and heme degradation.
Nagababu E; Ramasamy S; Rifkind JM; Jia Y; Alayash AI
Biochemistry; 2002 Jun; 41(23):7407-15. PubMed ID: 12044174
[TBL] [Abstract][Full Text] [Related]
10. First-generation blood substitutes: what have we learned? Biochemical and physiological perspectives.
Alayash AI; D'Agnillo F; Buehler PW
Expert Opin Biol Ther; 2007 May; 7(5):665-75. PubMed ID: 17477804
[TBL] [Abstract][Full Text] [Related]
11. Hemoglobin-based oxygen carriers: From mechanisms of toxicity and clearance to rational drug design.
Buehler PW; D'Agnillo F; Schaer DJ
Trends Mol Med; 2010 Oct; 16(10):447-57. PubMed ID: 20708968
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Biochemical and Biophysical Characterization of Hemoglobin-Based Oxygen Carrier Therapeutics: All HBOCs Are Not Created Equally.
Meng F; Kassa T; Jana S; Wood F; Zhang X; Jia Y; D'Agnillo F; Alayash AI
Bioconjug Chem; 2018 May; 29(5):1560-1575. PubMed ID: 29570272
[TBL] [Abstract][Full Text] [Related]
13. Engineering tyrosine electron transfer pathways decreases oxidative toxicity in hemoglobin: implications for blood substitute design.
Silkstone GG; Silkstone RS; Wilson MT; Simons M; Bülow L; Kallberg K; Ratanasopa K; Ronda L; Mozzarelli A; Reeder BJ; Cooper CE
Biochem J; 2016 Oct; 473(19):3371-83. PubMed ID: 27470146
[TBL] [Abstract][Full Text] [Related]
14. Current Challenges in the Development of Acellular Hemoglobin Oxygen Carriers by Protein Engineering.
Benitez Cardenas AS; Samuel PP; Olson JS
Shock; 2019 Oct; 52(1S Suppl 1):28-40. PubMed ID: 29112633
[TBL] [Abstract][Full Text] [Related]
15. Simulation of NO and O2 transport facilitated by polymerized hemoglobin solutions in an arteriole that takes into account wall shear stress-induced NO production.
Zhou Y; Cabrales P; Palmer AF
Biophys Chem; 2012 Mar; 162():45-60. PubMed ID: 22285312
[TBL] [Abstract][Full Text] [Related]
16. Hemoglobin-based red blood cell substitutes and nitric oxide.
Yu B; Bloch KD; Zapol WM
Trends Cardiovasc Med; 2009 Apr; 19(3):103-7. PubMed ID: 19679268
[TBL] [Abstract][Full Text] [Related]
17. Hemoglobin-Based Blood Substitutes and the Treatment of Sickle Cell Disease: More Harm than Help?
Alayash AI
Biomolecules; 2017 Jan; 7(1):. PubMed ID: 28054978
[TBL] [Abstract][Full Text] [Related]
18. Model of nitric oxide diffusion in an arteriole: impact of hemoglobin-based blood substitutes.
Kavdia M; Tsoukias NM; Popel AS
Am J Physiol Heart Circ Physiol; 2002 Jun; 282(6):H2245-53. PubMed ID: 12003834
[TBL] [Abstract][Full Text] [Related]
19. Tangential flow filtration facilitated fractionation and PEGylation of low and high-molecular weight polymerized hemoglobins and their biophysical properties.
Gu X; Savla C; Palmer AF
Biotechnol Bioeng; 2022 Jan; 119(1):176-186. PubMed ID: 34672363
[TBL] [Abstract][Full Text] [Related]
20. Preclinical In Vitro Safety Investigations of Submicron Sized Hemoglobin Based Oxygen Carrier HbMP-700.
Kao I; Xiong Y; Steffen A; Smuda K; Zhao L; Georgieva R; Pruss A; Bäumler H
Artif Organs; 2018 May; 42(5):549-559. PubMed ID: 29508415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
